Reporting parties 2 facts
Subject security 3 facts
Symbol
EYPT
Shares outstanding
82,695,711 shares
Ownership signal 2 facts
SEC evidence 5 facts
Form type
SCHEDULE 13G/A
Filing time
15 May 2026, 16:26:16 UTC
Event date
31 Mar 2026
Previous filing
24 Feb 2026
SEC filing
View on sec.gov

Key filing fact

Paradigm Biocapital Advisors LP disclosed 3.8% ownership in EyePoint, Inc. Common Stock, $0.001 par value per share (EYPT) on 31 Mar 2026.

Key facts

  • Paradigm Biocapital Advisors LP filed SCHEDULE 13G/A for EyePoint, Inc. Common Stock, $0.001 par value per share (EYPT).
  • Disclosed ownership: 3.8%.
  • Date of event: 31 Mar 2026.

Change

  • Previous schedule filing date: 24 Feb 2026.
  • Current filing was accepted on 15 May 2026, 16:26.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (4)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 3.8% 3,142,437 3,142,437 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 3.8% 3,142,437 3,142,437 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 3.8% 3,142,437 3,142,437 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 3.3% 2,769,062 2,769,062 0 /s/ David K. Kim David K. Kim / Authorized Signatory
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .